Gene editing technique developed in Switzerland shows promise in curing Stargardt disease, a rare genetic eye disease causing ...

Benchmark analysts have increased the price target for Belite Bio, Inc (NASDAQ:BLTE) shares to $79.00, up from the previous ...

Benchmark raised the firm’s price target on Belite Bio (BLTE) to $79 from $57 and keeps a Buy rating on the shares. After speaking to ...

Insmed is set to challenge the Duchenne muscular dystrophy (DMD) treatment space with its innovative gene therapy asset, ...

Needless to say that both pre-existing heart conditions and smoking independently may lead to heart disease risks; however, together, they can worsen the condition especially in vulnerable populations ...

The research could revolutionize therapies for complex conditions like autoimmune disease and cancer. The Tribune, now published from Chandigarh, started publication on February 2, 1881 ...

This is the heart-warming moment a couple discovered they had both planned a surprise proposal for each other on the same day. Sally Morton, 39, had planned to propose to her girlfriend, Leanne ...

Lily-Rae Merchant-O'Hanlon, 12, was diagnosed with Stargardt disease last December. The inherited condition causes blurriness in the central part of the eye and her mother, Emma Merchant ...

A new mega-database of half a million mutations may flag new ways of treating genetic disease, scientists say. When you purchase through links on our site, we may earn an affiliate commission.

Stargardt disease affects around one in 6,500 people and is therefore a rare disease. Those affected increasingly lose the ability to see in the center of their field of vision, which makes it ...

A collaboration between scientists at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and Beam Therapeutics has resulted in a new base editing therapy for Stargardt disease ...